CYP1-bioactivated 2,4-diaryl-substituted pyridine analogues with remarkable activity in a breast cancer in vitro model

Authors: Ketan Ruparelia, Dyan N. Ankrett, Kenneth J.M. Beresford et al.
Publication: Bioorganic & Medicinal Chemistry Letters
Published: Aug 1, 2026
Source: Crossref
Back to Search View Original Cite This Article

Related Articles

Synthesis of Novel Pyridine-Based Organophosphorus Compounds via Stabilized Phosphonium Ylides and Trialkylphosphites: Evaluation of Antioxidant, Anti-diabetic and Anti-inflammatory Activities

Marwa E. Muhammed, Owis Fazwi et al. - Dec 2026

Read More
Sulfur- and water-tolerant vanadium-substituted phosphomolybdic acid catalysts for NH3-SCR: Combined experimental and DFT studies

Lina Guo, Qi Ding et al. - Nov 2026

Read More
A benzimidazole-pyridine-based fluorescent sensor: experimental and theoretical insights into copper ion and gamma-ray detection

Leyla Öztürk, Eren Kasımfırtına et al. - Oct 2026

Read More
Theoretical design of novel selenium-substituted meso-aryl-BODIPYs as singlet‑oxygen photosensitizers with biomedical applicability

Mónica Moral, Antonio Fernández et al. - Sep 2026

Read More
Iron-coordinated piperazine-substituted silicon(IV) phthalocyanine for highly efficient photodynamic tumor therapy

Hongwei Huang, Chenhui Zhong et al. - Sep 2026

Read More
Journal Ideas PyMinds Charcha More
PORE

About

About Us

Resources

Help Center Research Guides Citescore

Legal

Terms of Service Privacy Policy Cookie Policy Accessibility

Connect

Contact Us
© 2026 PORE. Content available under CC BY-NC 4.0